These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18170971)

  • 21. Opportunistic infection strategy.
    Proj Inf Perspect; 2004 Jan; (37):11-5. PubMed ID: 15119284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Kaplan JE; Masur H; Holmes KK; McNeil MM; Schonberger LB; Navin TR; Hanson DL; Gross PA; Jaffe HW
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S1-11. PubMed ID: 8547495
    [No Abstract]   [Full Text] [Related]  

  • 24. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy.
    Sobottke R; Zarghooni K; Krengel M; Delank S; Seifert H; Fätkenheuer G; Ernestus I; Källicke T; Frangen T; Arasteh K; Oette M; Eysel P
    Spine (Phila Pa 1976); 2009 Jun; 34(13):E452-8. PubMed ID: 19478647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural history of the HIV infection and changes in the central nervous system].
    Gładysz A; Szymczak A; Simon K
    Przegl Epidemiol; 2002; 56 Suppl 1():6-16. PubMed ID: 12194231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing HIV. Part 3: Mechanisms of disease. 3.3 How HIV leads to opportunistic infections.
    Crowe SM; Kornbluth RS
    Med J Aust; 1996 Feb; 164(3):171-3. PubMed ID: 8628138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tuberculosis in HIV positive individuals].
    Balcells M ME
    Rev Chilena Infectol; 2009 Apr; 26(2):126-34. PubMed ID: 19621143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
    Brooks JT; Kaplan JE; Masur H
    Top HIV Med; 2009; 17(3):109-14. PubMed ID: 19675369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Opportunistic infections in patients with disordered immune status].
    Kossmann T; Morganti-Kossmann MC; Smith P; Decurtins M
    Unfallchirurg; 1993 Apr; 96(4):176-80. PubMed ID: 8484136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penicillium marneffei infection in HIV.
    Ustianowski AP; Sieu TP; Day JN
    Curr Opin Infect Dis; 2008 Feb; 21(1):31-6. PubMed ID: 18192783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fever of unknown origin in HIV/AIDS patients.
    Hot A; Schmulewitz L; Viard JP; Lortholary O
    Infect Dis Clin North Am; 2007 Dec; 21(4):1013-32, ix. PubMed ID: 18061087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.
    Denholm JT; Wright EJ; Street A; Sasadeusz JJ
    Haemophilia; 2009 Mar; 15(2):538-43. PubMed ID: 19187189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous infections associated with HIV/AIDS.
    Hogan MT
    Dermatol Clin; 2006 Oct; 24(4):473-95, vi. PubMed ID: 17010777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HIV and dentistry. Part 3. HIV infection: pathogenesis, epidemiology, definitions and classification].
    Schulten EA; Danner SA; Sjamsoedin DA; van der Waal I
    Ned Tijdschr Tandheelkd; 1994 Mar; 101(3):81-5. PubMed ID: 11830955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.
    O'Gorman MR; Zijenah LS
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S19-26. PubMed ID: 18228562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological complications of human immunodeficiency virus infection in Zimbabwe-2005.
    Mielke J
    J Neurovirol; 2005; 11 Suppl 3():23-5. PubMed ID: 16540450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.